TRIM51
geneOn this page
Also known as TRIM51A
Summary
TRIM51 (tripartite motif-containing 51, HGNC:19023) is a protein-coding gene on chromosome 11q12.1, encoding Tripartite motif-containing protein 51 (Q9BSJ1).
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm.
Source: NCBI Gene 84767 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 72 total
- MANE Select transcript:
NM_032681
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19023 |
| Approved symbol | TRIM51 |
| Name | tripartite motif-containing 51 |
| Location | 11q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TRIM51A |
| Ensembl gene | ENSG00000124900 |
| Ensembl biotype | protein_coding |
| Entrez | 84767 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000244891, ENST00000449290
RefSeq mRNA: 1 — MANE Select: NM_032681
NM_032681
Canonical transcript exons
ENST00000449290 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001667539 | 55891133 | 55891810 |
| ENSE00002471399 | 55883297 | 55883384 |
| ENSE00002497611 | 55888032 | 55888262 |
| ENSE00002506282 | 55888979 | 55889001 |
| ENSE00002528192 | 55885425 | 55885839 |
| ENSE00002528791 | 55889942 | 55890039 |
| ENSE00002528930 | 55886123 | 55886218 |
Expression profiles
Bgee: expression breadth tissue_specific, 3 present calls, max score 82.45.
Top tissues by expression
224 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.45 | gold quality |
| oocyte | CL:0000023 | 63.00 | gold quality |
| endothelial cell | CL:0000115 | 61.28 | gold quality |
| secondary oocyte | CL:0000655 | 60.13 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 55.02 | gold quality |
| buccal mucosa cell | CL:0002336 | 53.20 | gold quality |
| sperm | CL:0000019 | 52.50 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 51.92 | gold quality |
| lower lobe of lung | UBERON:0008949 | 51.61 | silver quality |
| vastus lateralis | UBERON:0001379 | 51.33 | gold quality |
| quadriceps femoris | UBERON:0001377 | 51.08 | gold quality |
| deltoid | UBERON:0001476 | 46.68 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 45.50 | gold quality |
| upper leg skin | UBERON:0004262 | 44.77 | silver quality |
| saphenous vein | UBERON:0007318 | 44.74 | gold quality |
| biceps brachii | UBERON:0001507 | 43.58 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| gingival epithelium | UBERON:0001949 | 42.52 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 42.01 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| entorhinal cortex | UBERON:0002728 | 41.28 | gold quality |
| gingiva | UBERON:0001828 | 41.23 | gold quality |
| oviduct epithelium | UBERON:0004804 | 41.16 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| parotid gland | UBERON:0001831 | 40.86 | gold quality |
| medulla oblongata | UBERON:0001896 | 40.78 | gold quality |
| medial globus pallidus | UBERON:0002477 | 40.77 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.77 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting TRIM51, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-197-3P | 98.09 | 69.23 | 1004 |
| HSA-MIR-4314 | 97.50 | 67.30 | 1369 |
Cross-species orthologs
0 orthologs
Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890), TRIM63 (ENSG00000158022)
Protein
Protein identifiers
Tripartite motif-containing protein 51 — Q9BSJ1 (reviewed: Q9BSJ1)
Alternative names: SPRY domain-containing protein 5
All UniProt accessions (1): Q9BSJ1
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the TRIM/RBCC family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BSJ1-1 | 1 | yes |
| Q9BSJ1-2 | 2 |
RefSeq proteins (1): NP_116070* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000315 | Znf_B-box | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR001870 | B30.2/SPRY | Domain |
| IPR003877 | SPRY_dom | Domain |
| IPR003879 | Butyrophylin_SPRY | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR013320 | ConA-like_dom_sf | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR043136 | B30.2/SPRY_sf | Homologous_superfamily |
| IPR050143 | TRIM/RBCC | Family |
Pfam: PF00622, PF15227
UniProt features (9 total): binding site 4, zinc finger region 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BSJ1-F1 | 86.80 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 93; 96; 115; 121
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, SOX10_TARGET_GENES, MIR1252_3P, MIR6739_3P, MIR619_5P, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP, chr11q12, GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP, GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN, JIANG_CORE_DUPLICON_GENES
GO Biological Process (2): regulation of gene expression (GO:0010468), innate immune response (GO:0045087)
GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
432 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRIM51 | SLC45A3 | Q96JT2 | 588 |
| TRIM51 | TRIM56 | Q9BRZ2 | 478 |
| TRIM51 | PRAMEF13 | Q5VWM6 | 477 |
| TRIM51 | OR8J3 | Q8NGG0 | 476 |
| TRIM51 | PRAMEF1 | O95521 | 474 |
| TRIM51 | PRAMEF11 | O60813 | 474 |
| TRIM51 | MS4A2 | Q01362 | 471 |
| TRIM51 | GATA2 | P23769 | 467 |
| TRIM51 | TRIM52 | Q96A61 | 459 |
| TRIM51 | TRIM54 | Q9BYV2 | 453 |
| TRIM51 | MS4A1 | P08984 | 451 |
| TRIM51 | KHDC1L | Q5JSQ8 | 448 |
| TRIM51 | OR5F1 | O95221 | 447 |
| TRIM51 | OR5D16 | Q8NGK9 | 446 |
| TRIM51 | OR4A15 | Q8NGL6 | 445 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM51 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| SPRY2 | TRIM51 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RNF40 | TRIM51 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MAGEA11 | TRIM51 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (6): TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Two-hybrid), TRIM51 (Affinity Capture-MS)
ESM2 similar proteins: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, C9J1S8, I1YAP6, K7N6K2, P0CI25, P0CI26, P15533, Q0PF16, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3ZEE5, Q587N6, Q587N7, Q5BN31, Q5C8T6, Q5C8T8, Q5C8U1, Q5C8U3, Q5C8U4, Q5D7H7, Q5D7H8, Q5D7I0, Q5D7I1, Q5D7I2, Q5D7I3, Q5D7I5, Q5D7I6, Q5D7I9, Q5D7J0
Diamond homologs: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, B0BLU1, C9J1S8, I1YAP6, O00478, O00481, O15344, O75677, O75678, O75679, O76064, P0CI25, P0CI26, P18892, P19474, P62603, P86448, P86449, Q13410, Q2HJ46, Q3C1V9, Q3TL54, Q4KLN8, Q5EBN2, Q5PQN2, Q5R4I2, Q5R996, Q61510, Q62556, Q6INS5, Q6MFY8, Q6UX41, Q6UXE8, Q6ZWI9, Q7T308
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | TRIM51 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
72 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 69 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
617 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:55888025:A:AG | acceptor_gain | 1.0000 |
| 11:55888029:CAG:C | acceptor_loss | 1.0000 |
| 11:55888030:A:AG | acceptor_gain | 1.0000 |
| 11:55888030:AGGAT:A | acceptor_loss | 1.0000 |
| 11:55888031:G:GT | acceptor_gain | 1.0000 |
| 11:55888031:GGA:G | acceptor_gain | 1.0000 |
| 11:55888031:GGAT:G | acceptor_gain | 1.0000 |
| 11:55888031:GGATT:G | acceptor_gain | 1.0000 |
| 11:55888208:A:T | donor_gain | 1.0000 |
| 11:55888259:CCAG:C | donor_loss | 1.0000 |
| 11:55888260:CAGG:C | donor_loss | 1.0000 |
| 11:55888261:AGG:A | donor_loss | 1.0000 |
| 11:55888262:GGTAT:G | donor_loss | 1.0000 |
| 11:55888263:GTATG:G | donor_loss | 1.0000 |
| 11:55889937:TGCA:T | acceptor_loss | 1.0000 |
| 11:55889938:GCA:G | acceptor_loss | 1.0000 |
| 11:55889939:CAGGT:C | acceptor_loss | 1.0000 |
| 11:55889940:A:AC | acceptor_loss | 1.0000 |
| 11:55889940:A:AG | acceptor_gain | 1.0000 |
| 11:55889940:AG:A | acceptor_gain | 1.0000 |
| 11:55889941:G:GC | acceptor_gain | 1.0000 |
| 11:55889941:G:T | acceptor_loss | 1.0000 |
| 11:55889941:GG:G | acceptor_gain | 1.0000 |
| 11:55889941:GGT:G | acceptor_gain | 1.0000 |
| 11:55889941:GGTA:G | acceptor_gain | 1.0000 |
| 11:55889941:GGTAT:G | acceptor_gain | 1.0000 |
| 11:55890037:GAG:G | donor_gain | 1.0000 |
| 11:55890037:GAGGT:G | donor_loss | 1.0000 |
| 11:55890038:AG:A | donor_gain | 1.0000 |
| 11:55890038:AGG:A | donor_loss | 1.0000 |
AlphaMissense
3036 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:55891537:T:C | F422L | 0.951 |
| 11:55891539:T:A | F422L | 0.951 |
| 11:55891539:T:G | F422L | 0.951 |
| 11:55885735:T:C | F103L | 0.929 |
| 11:55885737:C:A | F103L | 0.929 |
| 11:55885737:C:G | F103L | 0.929 |
| 11:55891507:T:C | F412L | 0.923 |
| 11:55891509:C:A | F412L | 0.923 |
| 11:55891509:C:G | F412L | 0.923 |
| 11:55890033:T:C | F285L | 0.906 |
| 11:55890035:C:A | F285L | 0.906 |
| 11:55890035:C:G | F285L | 0.906 |
| 11:55891405:T:C | F378L | 0.903 |
| 11:55891407:T:A | F378L | 0.903 |
| 11:55891407:T:G | F378L | 0.903 |
| 11:55885528:T:C | F34L | 0.901 |
| 11:55885530:T:A | F34L | 0.901 |
| 11:55885530:T:G | F34L | 0.901 |
| 11:55891279:T:C | F336L | 0.893 |
| 11:55891281:C:A | F336L | 0.893 |
| 11:55891281:C:G | F336L | 0.893 |
| 11:55886213:T:A | W168R | 0.892 |
| 11:55886213:T:C | W168R | 0.892 |
| 11:55891330:T:A | W353R | 0.890 |
| 11:55891330:T:C | W353R | 0.890 |
| 11:55891300:T:A | W343R | 0.888 |
| 11:55891300:T:C | W343R | 0.888 |
| 11:55891447:T:C | F392L | 0.888 |
| 11:55891449:T:A | F392L | 0.888 |
| 11:55891449:T:G | F392L | 0.888 |
dbSNP variants (sampled 300 via entrez): RS1000275832 (11:55883237 AGAG>A), RS1000644677 (11:55882247 A>C), RS1000710829 (11:55883368 A>T), RS1001004660 (11:55887366 A>G), RS1001015383 (11:55882004 T>C), RS1001099089 (11:55887077 G>A), RS1001233696 (11:55892035 GTC>G), RS1001674651 (11:55889575 C>A), RS1001771010 (11:55889346 A>G), RS1002100038 (11:55888243 C>G,T), RS1002683892 (11:55890667 A>G), RS1003127121 (11:55885321 A>G), RS1004066743 (11:55885817 A>C,G), RS1004616734 (11:55884095 C>T), RS1005145652 (11:55886352 AC>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003225_8 | Pelvic organ prolapse (moderate/severe) | 5.000000e-06 |
| GCST006916_3 | Attention deficit hyperactivity disorder | 4.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, decreases methylation | 2 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Rifampin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pelvic organ prolapse